Twist Bioscience Corporation Common Stock - relatórios financeiros trimestrais (NASDAQ:TWST)

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Trimestral Ano

Market Capitalization 3.67 B
Employee 979
Founded 2013
CEO Emily LeProust
Website www.twistbioscience.com
Headquarter Delaware, United States
FIGI BBG006KDCHJ4
Industry Diagnósticos e pesquisa

Receita total

Lucro líquido

Lucro básico por ação

Dívida total

Fluxo de caixa livre

Caixa e equivalentes de caixa

3.67 B Capitalização de mercado

Índice preço/lucro

-24.98

Índice preço/fluxo de caixa

4.9

Twist Bioscience Corporation

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.